Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.
about
Overview of ESBL-producing Enterobacteriaceae from a Nordic perspectiveClinical management of infections caused by multidrug-resistant EnterobacteriaceaeThe Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the EvidenceResults of an early intervention programme for patients with bacteraemia: analysis of prognostic factors and mortality.The β-Lacta test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine.Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infectionsSepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.Population Pharmacokinetic Analysis of Piperacillin/Tazobactam in Korean Patients with Acute InfectionsTreatment of febrile geriatric patients with suspected urinary tract infections in a hospital with high rates of ESBL producing bacteria: a cohort study.Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms.Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection.Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.The challenge of antibiotic resistance in haematology patients.Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.Should the patients colonized with extended-spectrum beta-lactamase-producing gram-negative bacilli (E-GNB) coming to hospital from the community with pneumonia get anti-E-GNB active empirical treatment?Prevalence, risk factors and antimicrobial susceptibility pattern of extended spectrum β-lactamase-producing bacteria in a tertiary care hospital.Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance.Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study.Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia.Incidence of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates that test susceptible to cephalosporins and aztreonam by the revised CLSI breakpoints.The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
P2860
Q27026917-996709A8-AB23-4431-BCD6-577B546F2EDFQ28246841-CD0224CA-7846-421F-8DEF-40E9CA111C6EQ33564316-E00FCA92-01D1-4B3A-89AC-4D76B899E183Q33716722-A5EEC5B8-6176-46B4-88FA-7654FCCD998EQ34298172-180A0447-623E-4A85-9C37-40C870E812F6Q35030247-C7F9E897-4FC1-45C9-AD10-9A75FB13126FQ36292068-F9C442FE-288E-4A21-AE15-02A8B58D1389Q37114901-1A902D02-5A76-4230-BD86-B50D0AB1E70BQ37205420-2C565E4C-7471-4C7C-9EBC-BD965D0C54A7Q37306664-FB805D3D-801F-4423-AA52-CE211CB6F26CQ37517046-75AEB75C-DA08-4A69-B94E-FDB6C7143D65Q37517993-70CEE9D5-32A7-43CA-AA06-97F1F4045D93Q37644572-882328A0-3B51-4FBF-BABE-2B39B2D769BDQ38185120-23B01E1D-CA90-4329-9781-D08CDCC1A260Q38613929-9D46A990-86F8-492A-B6C6-AE4994384C7FQ38681779-9BB1E61A-7233-434B-BC23-A8EA5A6694ABQ40346594-6FBD562E-C2A1-453E-B4E4-421545D67311Q40428378-8A0A665E-F7A2-4FF5-8D11-FD73D495FFEFQ40817143-63D6CD07-7F95-421A-8205-3EEB983B7FD3Q40834519-7C13CDE3-5A33-4DE1-9715-63AE9A659858Q40933499-E3E63EBB-C678-4B27-A461-5473B18C212AQ41094417-7DD63488-4221-47BD-A7CE-3FBC44196349Q41750938-1D5D8DFA-387A-4046-88D8-CEB9D45A38B9Q41779878-3B719369-FEBB-4586-B325-7A91C0DF5B93Q42210504-491416DF-1F79-4460-9F29-4FFCE025404C
P2860
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Impact of empirical treatment ...... . A multicentric cohort study.
@ast
Impact of empirical treatment ...... . A multicentric cohort study.
@en
type
label
Impact of empirical treatment ...... . A multicentric cohort study.
@ast
Impact of empirical treatment ...... . A multicentric cohort study.
@en
prefLabel
Impact of empirical treatment ...... . A multicentric cohort study.
@ast
Impact of empirical treatment ...... . A multicentric cohort study.
@en
P2093
P2860
P50
P356
P1476
Impact of empirical treatment ...... . A multicentric cohort study.
@en
P2093
Alberto Delgado
Alfonso Gutiérrez-Macías
Ana Fleites
Azucena Rodríguez
Elia Sirvent
Galo Peralta
Jose Angel Alava
Jose Antonio Capdevila
Juan Alonso
Maria Carmen Fariñas
P2860
P2888
P356
10.1186/1471-2334-12-245
P577
2012-10-05T00:00:00Z
P5875
P6179
1040678937